Table 3

Lp(a) levels by atherosclerotic disease history

Type of eventPatients
N=48 135
Lp(a) mg/dL
Median (IQR)
(n=29 765)
Lp(a) nmol/L
Median (IQR)
(n=18 370)
LDL-C mg/dL
Median (IQR)
(n=47 988)
Cardiovascular history
 MI, n (%)37 383 (77.7)18.2 (8.0–58.5)40.9 (14.8–155.0)75.0 (58.0–98.0)
 Ischaemic stroke, n (%)7568 (15.7)14.3 (7.0–45.8)41.0 (15.0–150.7)83.0 (62.0– 112.1)
Any PAD5925 (12.3)
 Limb artery revascularisation, n (%)3475 (7.2)19.6 (7.9–62.9)54.0 (18.0–175.0)77.7 (59.0– 102.0)
 Leg amputation, n (%)421 (0.9)26.8 (8.6–80.8)41.1 (18.4–162.3)78.0 (57.5– 101.0)
 Symptomatic PAD with ABI ≤0.9, n (%)3557 (7.4)21.2 (8.0–70.0)57.3 (17.9–185.0)83.0 (62.0– 111.0)
Medical history (n=48 135)
 Prior MI, n (%)35 088 (72.9)18.2 (8.0–57.9)40.0 (14.5–152.8)75.0 (58.0– 97.8)
 Prior ischaemic stroke, n (%)6037 (12.5)14.0 (7.0–41.9)40.0 (15.0–142.0)85.0 (63.8– 114.0)
 Prior PAD, n (%)4433 (9.2)21.0 (8.0–66.5)50.0 (16.8–171.8)83.0 (62.0– 110.0)
 Multiple events, n (%)2577 (5.4)18.3 (7.7–69.0)54.3 (16.9–182.0)76.2 (57.6– 102.5)
  • P<0.001 compared with patients with history of MI.

  • ABI, ankle brachial index; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); MI, myocardial infarction; PAD, peripheral artery disease.